Novartis Ends BioArctic Brain Delivery Program

Company BioArctic; Novartis Event Type Collaboration termination (source-gap recovery) Modality Transferrin-receptor brain-shuttle antibody delivery Asset BrainTransporter (undisclosed Novartis antibody) Target Transferrin receptor (shuttle); undisclosed antibody target Disease Area Neurological disease (undisclosed) Summary BioArctic disclosed at 21:30 CET on November 2 that Novartis will terminate the…